Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study.
Muta T, Masamoto Y, Yamamoto G, Kurahashi S, Kameoka Y, Ota S, Matsuki E, Ozeki K, Toyama T, Takahashi N, Kumode T, Aotsuka N, Yoshimura T, Tamura H, Omi A, Shibayama K, Watanabe A, Isobe Y, Kojima K, Takizawa J, Nagai H, Suzumiya J, Aoki S.
Muta T, et al. Among authors: shibayama k.
Int J Hematol. 2024 Nov 26. doi: 10.1007/s12185-024-03875-0. Online ahead of print.
Int J Hematol. 2024.
PMID: 39586984